IO Biotech

Scroll
Investment area
Novo Seeds
Region
Europe
Date of investment
January 2014
Website
http://iobiotech.com

IO Biotech is a clinical stage biotech company developing distruptive immune therapies for immunological treatment of cancer.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more